On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1450 AM Holland, MI

Weather

Current Conditions(Holland,MI 49422)

More Weather »
41° Feels Like: 37°
Wind: ESE 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 33°

Tomorrow

Mostly Sunny 64°

Sun Night

Partly Cloudy 40°

Alerts

Spectrum Pharma's blood cancer drug meets goal in mid-stage trial

(Reuters) - Spectrum Pharmaceuticals Inc said a mid-stage trial of its experimental blood cancer drug met the main goal of shrinking tumors.

The drug, belinostat, was tested in patients with relapsed/refractory peripheral T-Cell (PTCL) lymphoma, who have failed at least one therapy.

The biotechnology company said it expects to file a marketing application with U.S. health regulators by mid-2013, and expects a review date in 2014.

Belinostat was granted orphan-drug status and fast-track status by the U.S. Food and Drug Administration for PTCL.

Spectrum's shares, which have fallen about 22 percent in the last year, closed at $11.30 on the Nasdaq on Thursday.

(Reporting By Vrinda Manocha in Bangalore; Editing by Don Sebastian)

Comments